Christian Bréchot Appointed to bioMerieux SA’s Board

June 12, 2008 |

1 min read

MARCY L'ETOILE, France--(BUSINESS WIRE)-- Regulatory News: Professor Christian Bréchot has been appointed to the Board of Directors of bioMérieux S.A. (Paris:BIM) during its Annual Shareholder’s Meeting, held on June 12th.

People Europe

MORE ON THIS TOPIC

Contemporary art collage. Purple hand holding fan of dollar bills against bright yellow background. stock photo

Venture capital

Ambros Launches With $125M To Bring Italian Non-Opioid Pain Drug to America

December 16, 2025

·

1 min read

·

Annalee Armstrong

Illustration of businessman running back around

Autoimmune disease

Sanofi Taps Dren Again in up to $1.7B Autoimmune Partnership

December 15, 2025

·

1 min read

·

Annalee Armstrong

Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.

Mergers & acquisitions

Sobi Makes $1.5B Gout Play With Arthrosi Acquisition

December 15, 2025

·

2 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Pfizer, Geron Downsize To Streamline Costs

December 12, 2025

·

95 min read

·

BioSpace Editorial Staff